Company news
Underwood Capital Limited (ASX:UWC) news
Every Underwood Capital Limited press release and news update in one place — announcements, filings coverage, and company updates for investors.
Press releases & updates
FY26 UWC Appendix 4E and Annual Report
August 24, 2026
Half Yearly Report and Accounts
February 25, 2026
UWC Extension of OnMarket Share Buyback
October 6, 2025
FY25 UWC Appendix 4E and Annual Report
August 24, 2025
UWC Appendix 4D and financial statements
February 20, 2025
HGV Sale of Shares in Emerging Therapeutics Group Pty Ltd
September 24, 2024
HGV Capital Management Initiative
September 23, 2024
Half Year Accounts
February 26, 2024
2023 Appendix 4E and Annual Report
August 30, 2023
HGV ANNOUNCES APPOINTMENT OF NEW INVESTMENT MANAGER
August 23, 2023
HGV Makes Follow-on Investment In Weed Me Inc
April 26, 2023
HGV ANNOUNCES TENDER FOR INVESTMENT MANAGER
February 24, 2023
HGV extends the term of Parallax Ventures as Asset Manager
September 19, 2022
Preliminary Final Report
August 30, 2022
HGV AGREES TO DIVEST ITS INVESTMENT IN ENTOURAGE HEALTH
May 16, 2022
MMJ Group invests AUD1m in Valo Therapeutics
November 15, 2021
Embark Health Investment Update
December 10, 2020
MMJ Appendix 4D
February 23, 2020
Share Purchase Plan
February 13, 2020
MMJ enters CAD2m secured loan agreement with Harvest One
January 13, 2020
MMJ Group invests CAD3.6m in Embark Health Inc.
October 16, 2019
MMJ Group Invests CAD6m in WeedMD Inc.
September 25, 2019
MMJ makes investment in Polish Cannabis Extraction Business
July 22, 2019
Appendix 4D and Half Year Accounts
July 1, 2019
Capital Management and Embark Ventures Appointment
June 6, 2019
MMJ Investor Update
May 8, 2019
MMJ to appoint Embark as Asset Manager and cancel SPP
April 15, 2019
Trading Halt
April 14, 2019
Capital raising in 2019 an update
February 21, 2019
CEO resignation
February 3, 2019
MediPharm Labs extraction agreement with TerrAscend
January 8, 2019
Reinstatement to Official Quotation
December 19, 2018
Suspension and planned share purchase plan in 2019
December 19, 2018
Suspension from Official Quotation
December 12, 2018
Pause in Trading
December 12, 2018
Investor presentation
November 20, 2018
Further investment in Embark
November 11, 2018
Appendix 4C - quarterly
October 28, 2018
Portfolio management update
October 26, 2018
Update on PTL Disposal and MMJ Suspension
October 10, 2018
MediPharm Labs enters contract with Emerald
October 10, 2018
Results of Meeting
October 5, 2018
Update on the PTL Disposal
October 5, 2018
Prospectus
September 30, 2018
Postponement of General Meeting
September 28, 2018
OCS supply agreements for MMJ investee companies
September 6, 2018
MediPharm signs customer contracts ahead of TSX-V listing
September 5, 2018
PTL completes Phase 2 clinical trial
July 24, 2018
Appendix 4C
July 23, 2018
Investment in Embark Health
July 16, 2018